The DOI matches its Crossref record; 78 of the 79 references it cites were found in a registry or an index.
Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
Open accessPublished version of a preprint
Abstract
BACKGROUND: Circulating lipoprotein lipids cause coronary heart disease (CHD). However, the precise way in which one or more lipoprotein lipid-related entities account for this relationship remains unclear. Using genetic instruments for lipoprotein lipid traits implemented through multivariable Mendelian randomisation (MR), we sought to compare their causal roles in the aetiology of CHD. METHODS AND FINDINGS: We conducted a genome-wide association study (GWAS) of circulating non-fasted lipoprotein lipid traits in the UK Biobank (UKBB) for low-density lipoprotein (LDL) cholesterol, triglycerides, and apolipoprotein B to identify lipid-associated single nucleotide polymorphisms (SNPs). Using data from CARDIoGRAMplusC4D for CHD (consisting of 60,801 cases and 123,504 controls), we performed univariable and multivariable MR analyses. Similar GWAS and MR analyses were conducted for high-density lipoprotein (HDL) cholesterol and apolipoprotein A-I. The GWAS of lipids and apolipoproteins in the UKBB included between 393,193 and 441,016 individuals in whom the mean age was 56.9 y (range 39-73 y) and of whom 54.2% were women. The mean (standard deviation) lipid concentrations were LDL cholesterol 3.57 (0.87) mmol/L and HDL cholesterol 1.45 (0.38) mmol/L, and the median triglycerides was 1.50 (IQR = 1.11) mmol/L. The mean (standard deviation) values for apolipoproteins B and A-I were 1.03 (0.24) g/L and 1.54 (0.27) g/L, respectively. The GWAS identified multiple independent SNPs associated at P < 5 × 10-8 for LDL cholesterol (220), apolipoprotein B (n = 255), triglycerides (440), HDL cholesterol (534), and apolipoprotein A-I (440). Between 56%-93% of SNPs identified for each lipid trait had not been previously reported in large-scale GWASs. Almost half (46%) of these SNPs were associated at P < 5 × 10-8 with more than one lipid-related trait. Assessed individually using MR, LDL cholesterol (odds ratio [OR] 1.66 per 1-standard-deviation-higher trait; 95% CI: 1.49-1.86; P < 0.001), triglycerides (OR 1.34; 95% CI: 1.25-1.44; P < 0.001) and apolipoprotein B (OR 1.73; 95% CI: 1.56-1.91; P < 0.001) had effect estimates consistent with a higher risk of CHD. In multivariable MR, only apolipoprotein B (OR 1.92; 95% CI: 1.31-2.81; P < 0.001) retained a robust effect, with the estimate for LDL cholesterol (OR 0.85; 95% CI: 0.57-1.27; P = 0.44) reversing and that of triglycerides (OR 1.12; 95% CI: 1.02-1.23; P = 0.01) becoming weaker. Individual MR analyses showed a 1-standard-deviation-higher HDL cholesterol (OR 0.80; 95% CI: 0.75-0.86; P < 0.001) and apolipoprotein A-I (OR 0.83; 95% CI: 0.77-0.89; P < 0.001) to lower the risk of CHD, but these effect estimates attenuated substantially to the null on accounting for apolipoprotein B. A limitation is that, owing to the nature of lipoprotein metabolism, measures related to the composition of lipoprotein particles are highly correlated, creating a challenge in making exclusive interpretations on causation of individual components. CONCLUSIONS: These findings suggest that apolipoprotein B is the predominant trait that accounts for the aetiological relationship of lipoprotein lipids with risk of CHD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hypertriglyceridemia is indirectly linked with changes in HDL-C and LDL-C composition that are conducive to accelerated atherogenesis.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [312]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence from prospective longitudinal cohort studies and Mendelian randomization support a strong, dose-dependent relationship between LDL-C levels and ASCVD incidence [2, 3].”
From Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“From this perspective, triglycerides chiefly index TRL particle burden rather than act as an independent atherogen, and causal inferences often attenuate when apoB is accounted for in multivariable genetic analyses [2].”
From Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At the same time, it is important to recognize that apoB remains the most informative single summary measure of atherogenic risk, as LDL apoB numerically dominates total apoB in most individuals; accordingly, the benefits of lipid-lowering therapy appear to correlate more closely with reductions in apoB (particle number) than with triglyceride lowering alone [2, 18, 19].”
From Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We also highlight that apoB is the most robust integrative metric of atherogenic particle exposure, with some trial benefits aligning more strongly with apoB reduction than with triglyceride lowering alone [2, 18].”
From Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies (2026) · cites this paper as [2]
Experimental — accuracy not yet measured
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
ggplot2: Elegant Graphics for Data Analysis
Ginestet, C. (2011) · Journal of the Royal Statistical Society Series A: Statistics in Society · doi:10.1111/j.1467-985x.2010.00676_9.x · Cited by 13,726
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728
Second-generation PLINK: rising to the challenge of larger and richer datasets
Chang, C. C., Chow, C. C., Tellier, L. C., Vattikuti, S., Purcell, S. M., & Lee, J. J. (2015) · Gigascience · doi:10.1186/s13742-015-0047-8 · Cited by 12,709
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Self-citationBowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922 · cited 2×
“The repertoire of robust univariable MR approaches [51] that seek to act as sensitivity analyses for potential unbalanced horizontal pleiotropy each make a different series of assumptions [53].”
BackgroundMethodThe UK Biobank resource with deep phenotyping and genomic data
Bycroft, C., Freeman, C., Petkova, D., Band, G., Elliott, L. T., Sharp, K., Motyer, A., Vukcevic, D., Delaneau, O., O’Connell, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0579-z · Cited by 8,876
The MR-Base platform supports systematic causal inference across the human phenome
Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959
Research works printed but not linked: 1
- D Fry, 2019, Companion Document to Accompany Serum Biomarker Data, UK Biobank Biomarker Project
Cited by
Items 101–200 of 903
Genetics of hypertriglyceridemia and atherosclerosis
Gill, P. K., Dron, J. S., & Hegele, R. A. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000839 · Cited by 41
Chen, J., Zhou, H., Jin, H., & Liu, K. (2022) · Nutrients · doi:10.3390/nu14204434 · Cited by 44
Lipids, lipid-lowering agents, and inflammatory bowel disease: a Mendelian randomization study
Tao, H., Zhou, Y., Dong, Y., Liu, L., Peng, L., & Chen, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1160312 · Cited by 43
Zhou, X., Lian, P., Liu, H., Wang, Y., Zhou, M., & Feng, Z. (2023) · Nutrients · doi:10.3390/nu15204445 · Cited by 42
Larsson, S. C., Michaëlsson, K., Mola-Caminal, M., Höijer, J., & Mantzoros, C. S. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155329 · Cited by 41
Long-term fasting improves lipoprotein-associated atherogenic risk in humans
Grundler, F., Plonné, D., Mesnage, R., Müller, D., Sirtori, C. R., Ruscica, M., & de Toledo, F. W. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02578-0 · Cited by 47
Machine Learning and Deep Learning Techniques on Accurate Risk Prediction of Coronary Heart Disease
Gangadhar, M. S., Sai, K. V. S., Kumar, S. H. S., Kumar, K. A., Kavitha, M., & Aravinth, S. S. (2023) · International Conference on Computing Methodologies and Communication (ICCMC) · doi:10.1109/iccmc56507.2023.10083756 · Cited by 37
Mak, J. K. L., Kananen, L., Qin, C., Kuja‐Halkola, R., Tang, B., Lin, J., Wang, Y., Jääskeläinen, T., Koskinen, S. V. P., Lu, Y., et al. (2023) · Aging Cell · doi:10.1111/acel.13868 · Cited by 36
Yang, S., Pudasaini, R., Zhi, H., & Wang, L. (2021) · Nutrients · doi:10.3390/nu14010181 · Cited by 41
Venkateswaran, N., Feldman, J., Hawkins, S. R., Lewis, M. A., Armstrong-Brown, J., Comfort, M. L., Lowe, A., & Pineda, D. (2023) · doi:10.3768/rtipress.2023.op.0085.2301 · Cited by 46
Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk
Gobeil, É., Bourgault, J., Mitchell, P. L., Houessou, U., Gagnon, É., Girard, A. S., Paulin, A., Manikpurage, H. D., Côté, V., Couture, C., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehad845 · Cited by 37
The “Common Soil Hypothesis” Revisited—Risk Factors for Type 2 Diabetes and Cardiovascular Disease
Silva, L. F., Vangipurapu, J., & Laakso, M. (2021) · Metabolites · doi:10.3390/metabo11100691 · Cited by 38
2022 Taiwan lipid guidelines for primary prevention
Huang, P., Lu, Y., Tsai, Y., Wu, Y., Li, H., Chang, H.-Y., Wu, C., Yang, C., Tarng, D., Huang, C., et al. (2022) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2022.05.010 · Cited by 44
ANGPTL3 Deficiency and Risk of Hepatic Steatosis
D’Erasmo, L., Martino, M. D., Neufeld, T., Fraum, T. J., Kang, C. J., Burks, K. H., Costanzo, A. D., Minicocci, I., Bini, S., Maranghi, M., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.065866 · Cited by 37
Hoek, A. G., van Oort, S., Elders, P. J. M., & Beulens, J. W. J. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.025644 · Cited by 35
Schlosser, P., Zhang, J., Liu, H., Surapaneni, A., Rhee, E. P., Arking, D. E., Yu, B., Boerwinkle, E., Welling, P. A., Chatterjee, N., et al. (2023) · Genome biology · doi:10.1186/s13059-023-02993-y · Cited by 37
Li, J., Li, C., Huang, Y., Guan, P., Huang, D., Yu, H., Yang, X., & Liu, L. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03822-9 · Cited by 36
Zuber, V., Lewin, A., Levin, M. G., Haglund, A., Ben‐Aicha, S., Emanueli, C., Damrauer, S. M., Burgess, S., Gill, D., & Bottolo, L. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.06.005 · Cited by 34
Keshawarz, A., Bui, H., Joehanes, R., Ma, J., Liu, C., Huan, T., Hwang, S., Tejada, B., Sooda, M., Courchesne, P. L., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-39936-3 · Cited by 38
Templehof, H., Moshe, N., Avraham‐Davidi, I., & Yaniv, K. (2021) · JCI Insight · doi:10.1172/jci.insight.130399 · Cited by 32
Association of genetically predicted lipid traits and lipid-modifying targets with heart failure
Xiao, J., Ji, J., Zhang, N., Yang, X., Chen, K., Chen, L., & Huang, W. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac290 · Cited by 32
Dai, H., Hou, T., Wang, Q., Hou, Y., Zhu, Z., Zhu, Y., Zhao, Z., Li, M., Lin, H., Wang, S., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02045-6 · Cited by 35
Neutrophil extracellular traps: a catalyst for atherosclerosis
Wang, Y., Wang, C., & Li, J. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-04931-3 · Cited by 34
Ye, C., Kong, L., Zhao, Z., Li, M., Wang, S., Lin, H., Xu, Y., Lu, J., Chen, Y., Xu, Y., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab633 · Cited by 37
European guidelines for the treatment of dyslipidaemias: New concepts and future challenges
Pirillo, A., Casula, M., & Catapano, A. L. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106936 · Cited by 42
Z-flipon variants reveal the many roles of Z-DNA and Z-RNA in health and disease
Umerenkov, D., Herbert, A. G., Konovalov, D., Danilova, A., Beknazarov, N., Kokh, V., Fedorov, A., & Poptsova, M. S. (2023) · Life Science Alliance · doi:10.26508/lsa.202301962 · Cited by 37
Multi-scale inference of genetic trait architecture using biologically annotated neural networks
Demetçi, P., Cheng, W., Darnell, G., Zhou, X., Ramachandran, S., & Crawford, L. A. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009754 · Cited by 33
Leyden, G. M., Shapland, C. Y., Smith, G. D., Sanderson, E. C. M., Greenwood, M. P., Murphy, D., & Richardson, T. G. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.12.013 · Cited by 30
Self-citationHelgadottir, A., Thorleifsson, G., Snaebjarnarson, A., Stefansdottir, L., Sveinbjornsson, G., Tragante, V., Björnsson, E., Steinthorsdottir, V., Gretarsdottir, S., Helgason, H., et al. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac219 · Cited by 30
Omega-3 fatty acids and major depression: a Mendelian randomization study
Carnegie, R., Borges, M. C., Jones, H. J., Zheng, J., Haycock, P., Evans, J., & Martin, R. M. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02932-w · Cited by 37
ApoPred: Identification of Apolipoproteins and Their Subfamilies With Multifarious Features
Liu, T., Chen, J., Zhang, D., Zhang, Q., Peng, B., Xu, L., & Tang, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.621144 · Cited by 35
Trinder, M., Zekavat, S. M., Uddin, M. M., Pampana, A., & Natarajan, P. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab060 · Cited by 30
A BAFF/APRIL axis regulates obesogenic diet-driven weight gain
Chan, C. C., Harley, I. T. W., Pfluger, P. T., Trompette, A., Stankiewicz, T. E., Allen, J. L., Moreno‐Fernandez, M. E., Damen, M. S. M. A., Oates, J. R., Alarcon, P. C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23084-1 · Cited by 35
Janse van Mantgem, M. R., van Rheenen, W., Hackeng, A. V., van Es, M. A., Veldink, J. H., van den Berg, L. H., & van Eijk, R. P. A. (2023) · Neurology · doi:10.1212/wnl.0000000000201657 · Cited by 28
“For all individuals who were enrolled in both our population-based registry and our latest genome-wide association study (GWAS),5 we calculated the PPS. PPS was based on summary statistics from a GWAS on biomarker levels of lipid metabolism in the UK Biobank.31 For each e1064 Neurology | Volume 100, Number 10 | March…”
MethodInoue, K., Naito, T., Fuji, R., Sonehara, K., Yamamoto, K., Baba, R., Kodama, T., Otagaki, Y., Okada, A., Itcho, K., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.034180 · Cited by 32
Rasheed, H., Zheng, J., Rees, J. M. B., Sanderson, E. C. M., Thomas, L. F., Richardson, T. G., Fang, S., Bekkevold, O.-J., Stovner, E. B., Gabrielsen, M. E., et al. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyab014 · Cited by 28
Self-citationSkampardoni, I., Nasrallah, I. M., Abdulkadir, A., Wen, J., Melhem, R., Mamourian, E., Erus, G., Doshi, J., Singh, A., Yang, Z., et al. (2024) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.5599 · Cited by 28
Li, D., Lin, J., Yang, H., Zhou, L., Li, Y., Xu, Z., Sun, L. N., Zhang, X., Xu, W., & Wang, Y. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02790-w · Cited by 37
Li, M., Zhao, J. V., Kwok, M. K., & Schooling, C. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-88256-x · Cited by 26
Fang, S., Holmes, M. V., Gaunt, T. R., Smith, G. D., & Richardson, T. G. (2022) · eLife · doi:10.7554/elife.73951 · Cited by 29
Self-citationSchmidt, A. F., Joshi, R., Gordillo‐Marañón, M., Drenos, F., Charoen, P., Giambartolomei, C., Bis, J. C., Gaunt, T. R., Hughes, A. D., Lawlor, D. A., et al. (2023) · Communications Medicine · doi:10.1038/s43856-022-00234-0 · Cited by 33
Lipids and amyotrophic lateral sclerosis: A two‐sample Mendelian randomization study
Xia, K., Klose, V., Högel, J., Huang, T., Zhang, L., Dorst, J., Fan, D., & Ludolph, A. C. (2023) · European Journal of Neurology · doi:10.1111/ene.15810 · Cited by 27
“separately [21] by including 393,193 to 441,016 individuals.”
BackgroundGergei, I., Zheng, J., Andlauer, T. F. M., Brandenburg, V. M., Mirza‐Schreiber, N., Müller‐Myhsok, B., Krämer, B. K., Richard, D. J., Falk, L., Movérare‐Skrtic, S., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab263 · Cited by 28
Ghatan, S., van Rooij, J., van Hoek, M., Boer, C. G., Felix, J. F., Kavousi, M., Jaddoe, V. W. V., Sijbrands, E. J. G., Medina‐Gómez, C., Rivadeneira, F., et al. (2024) · Genome Medicine · doi:10.1186/s13073-023-01255-7 · Cited by 32
Gao, C., Marcketta, A., Backman, J., O’Dushlaine, C. T., Staples, J. C., Ferreira, M. A. R., Lotta, L. A., Overton, J. D., Reid, J. G., Mirshahi, T., et al. (2021) · Genetic Epidemiology · doi:10.1002/gepi.22392 · Cited by 28
Martin, L., Boutwell, B. B., Messerlian, C., & Adams, C. D. (2024) · Communications Biology · doi:10.1038/s42003-024-05887-2 · Cited by 27
Chen, L., Sun, X., He, Y., Lu, Y., & Zheng, L. (2022) · BMC Medical Genomics · doi:10.1186/s12920-022-01180-5 · Cited by 25
Common and Rare 5′UTR Variants Altering Upstream Open Reading Frames in Cardiovascular Genomics
Soukarieh, O., Meguerditchian, C., Proust, C., Aïssi, D., Eyries, M., Goyenvalle, A., & Trégouët, D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.841032 · Cited by 25
Dyslipidemia: A Narrative Review on Pharmacotherapy
de Oliveira, L. D., de Assis, A. C. R., Giraldez, V. Z. R., Scudeler, T. L., & Soares, P. R. (2024) · Pharmaceuticals · doi:10.3390/ph17030289 · Cited by 30
Dose-Response Associations of Lipid Traits With Coronary Artery Disease and Mortality
Yang, G., Mason, A. M., Wood, A., Schooling, C. M., & Burgess, S. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.52572 · Cited by 31
Greve, A. M., Wulff, A. B., Bojesen, S. E., & Nordestgaard, B. G. (2024) · British Journal of Dermatology · doi:10.1093/bjd/ljae089 · Cited by 27
Apolipoprotein B - An ideal biomarker for atherosclerosis?
Singh, K., & Prabhakaran, D. (2024) · Indian Heart Journal · doi:10.1016/j.ihj.2023.12.001 · Cited by 30
Kraaijenhof, J. M., Kerkvliet, M., Nurmohamed, N. S., Grefhorst, A., Kroon, J., Wareham, N. J., Hovingh, G. K., Stroes, E. S. G., Boekholdt, S. M., & Reeskamp, L. F. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf037 · Cited by 33
Gut microbiota composition in colorectal cancer patients is genetically regulated
Colombo, F., Illescas, O., Noci, S., Minnai, F., Pintarelli, G., Pettinicchio, A., Vannelli, A., Sorrentino, L., Battaglia, L., Cosimelli, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15230-6 · Cited by 25
Landfors, F., Chorell, E., & Kersten, S. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100313 · Cited by 25
Chu, C., Liu, S., Nie, L., Hu, H., Liu, Y., & Yang, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116305 · Cited by 30
Small, A. M., Melloni, G. E. M., Kamanu, F. K., Bergmark, B. A., Bonaca, M. P., O’Donoghue, M. L., Giugliano, R. P., Scirica, B. M., Bhatt, D., Antman, E. M., et al. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2024.0011 · Cited by 23
Mahmood, T., Rehman, A. U., Saba, T., Alahmadi, T. J., Tufail, M., Bahaj, S. A., & Ahmad, Z. (2024) · IEEE Access · doi:10.1109/access.2024.3435948 · Cited by 29
The Inherited Basis of Coronary Artery Disease
Schunkert, H., Natarajan, P., & Samani, N. J. (2026) · New England Journal of Medicine · doi:10.1056/nejmra2405153 · Cited by 25
Obesity Partially Mediates the Diabetogenic Effect of Lowering LDL Cholesterol
Wu, P., Moon, J., Daghlas, I., Giulianini, F., Porneala, B., Ahmadizar, F., Richardson, T. G., Isaksen, J. L., Hindy, G., Yao, J., et al. (2021) · Diabetes Care · doi:10.2337/dc21-1284 · Cited by 25
Self-citationMa, J., Joehanes, R., Liu, C., Keshawarz, A., Hwang, S., Bui, H., Tejada, B., Sooda, M., Munson, P. J., Demirkale, C. Y., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-24100-0 · Cited by 25
Giontella, A., Zagkos, L., Geybels, M. S., Larsson, S. C., Tzoulaki, I., Mantzoros, C. S., Andersen, B., Gill, D., & Cronjé, H. T. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155616 · Cited by 22
Zhang, Z.-Y.-O., Jian, Z., Tang, Y., & Li, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1174998 · Cited by 27
Complex effects of sequence variants on lipid levels and coronary artery disease
Snæbjarnarson, A. S., Helgadóttir, A., Arnadottir, G. A., Ivarsdottir, E. V., Þorleifsson, G., Ferkingstad, E., Einarsson, G., Sveinbjörnsson, G., Thorgeirsson, T. E., Ulfarsson, M. O., et al. (2023) · Cell · doi:10.1016/j.cell.2023.08.012 · Cited by 23
Tracking of serum lipid levels from childhood to adulthood: Systematic review and meta-analysis
Stanesby, O., Armstrong, M. K., Otáhal, P., Goode, J. P., Fraser, B. J., Negishi, K., Kidokoro, T., Winzenberg, T. M., Juonala, M., Wu, F., et al. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117482 · Cited by 25
Katsi, V. K., Argyriou, N., Fragoulis, C., & Tsioufis, K. P. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12070256 · Cited by 38
Ballantyne, C. M., & Norata, G. D. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf606 · Cited by 24
DICORPO, D. A., Gaynor, S. M., Russell, E. M., Westerman, K. E., Raffield, L. M., Majarian, T. D., Wu, P., Sarnowski, C., Highland, H. M., Jackson, A., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03702-4 · Cited by 26
Yeh, K.-H., Wan, H., Teng, M., Chou, H., Hsu, L., & Ko, Y. (2022) · Genes · doi:10.3390/genes13081366 · Cited by 22
Li, T., Yuan, D., Wang, P., Jia, S., Zhang, C., Zhu, P., Song, Y., Tang, X., Zhao, X., Gao, Z., et al. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01733-8 · Cited by 23
Multiset correlation and factor analysis enables exploration of multi-omics data
Brown, B. C., Wang, C., Kasela, S., Aguet, F., Nachun, D. C., Taylor, K. D., Tracy, R. P., Durda, P., Liu, Y., Johnson, W. C., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100359 · Cited by 23
McGrath, I. M., Montgomery, G. W., & Mortlock, S. (2023) · BMC Medicine · doi:10.1186/s12916-023-03184-z · Cited by 25
Mendelian randomization studies on coronary artery disease: a systematic review and meta-analysis
Silva, S., Fatumo, S., & Nitsch, D. (2024) · Systematic Reviews · doi:10.1186/s13643-023-02442-8 · Cited by 26
Apolipoprotein B: the Rosetta Stone of lipidology
Glavinovic, T., & Sniderman, A. D. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000596 · Cited by 22
León‐Mimila, P., Villamil‐Ramírez, H., Kauffer, L. R. M., Jacobo‐Albavera, L., López-Contreras, B. E., Posadas‐Sánchez, R., Posadas‐Romero, C., Romero‐Hidalgo, S., Morán‐Ramos, S., Domínguez‐Pérez, M., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315391 · Cited by 26
Effects of blood lipids and lipid‐modifying drugs on intracranial aneurysms
Zhang, B., Dong, S., Miao, Y., Song, G., Yuan, F., Liu, L., Xia, S., Qin, Y., Huo, X., Wu, Z., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15471 · Cited by 23
He, Q., Wang, W., Li, H., Xiong, Y., Tao, C., Ma, L., & You, C. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231169838 · Cited by 21
The Causal Effects of Lipid Profiles on Sleep Apnea
Tang, H., Zhou, Q. T., Zheng, F., Wu, T., Tang, Y., & Jiang, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.910690 · Cited by 24
Generalization of cortical MOSTest genome-wide associations within and across samples
Loughnan, R. J., Shadrin, A. A., Frei, O., van der Meer, D., Zhao, W., Palmer, C. E., Thompson, W. K., Makowski, C., Jernigan, T. L., Andreassen, O. A., et al. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119632 · Cited by 17
Pan, Y., Wen, J., Ning, Z., Yuan, Y., Liu, X., Yang, Y., Guan, Y., Lü, Y., Mamatyusupu, D., & Xu, S. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad054 · Cited by 23
Chen, C., Zhang, H., Lan, Y., Yan, W., Liu, S., Chen, Y., Xie, T., Ning, J., Yan, X., Shang, L., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05097-8 · Cited by 23
Richardson, T. G., Fang, S., Mitchell, R. E., Holmes, M. V., & Smith, G. D. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103228 · Cited by 20
Self-citationZorn, S., Bounds, R., Williamson, A., Lawler, K., Hanßen, R., Keogh, J. M., Henning, E., Smith, M., Fielding, B. A., Umpleby, A. M., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03976-1 · Cited by 27
Zhang, T., Yeung, S. L. A., & Schooling, C. M. (2021) · Nutrients · doi:10.3390/nu13051489 · Cited by 21
Smith, S. P., Shahamatdar, S., Cheng, W., Zhang, S., Paik, J., Graff, M., Haiman, C. A., Matise, T. C., North, K. E., Peters, U., et al. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.03.005 · Cited by 29
Jørsboe, E., Andersen, M. K., Skotte, L., Stæger, F. F., Færgeman, N. J., Hanghøj, K., Santander, C. G., Senftleber, N. K., Díaz, L. J., Overvad, M., et al. (2022) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2022.100118 · Cited by 20
Genetic determinants of pancreatitis: relevance in severe hypertriglyceridemia
Hang, S., Hegele, R. A., & Berberich, A. J. (2023) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000866 · Cited by 20
Hassen, C. B., Machado‐Fragua, M. D., Landré, B., Fayossé, A., Dumurgier, J., Kivimäki, M., Sabia, S., & Singh‐Manoux, A. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13140 · Cited by 21
Zhang, X., Chen, K., Yin, S.-Y., Qian, M., & Liu, C. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1158810 · Cited by 24
Mendelian randomization analysis revealed potential metabolic causal factors for breast cancer
Zhou, M., Henricks, M., Loch, V., Zhang, G. X., Lu, Y., & Li, X. (2023) · Scientific Reports · doi:10.1038/s41598-023-41130-4 · Cited by 26
Jin, D., Trichia, E., Islam, N., Bešević, J., Lewington, S., & Lacey, B. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.029552 · Cited by 21
Zhang, Z., Duan, Y., & Huo, J. (2023) · Calcified Tissue International · doi:10.1007/s00223-023-01160-6 · Cited by 20
Wang, W., Li, W., Zhang, D., Mi, Y., Zhang, J., & He, G. (2024) · Genes · doi:10.3390/genes15010132 · Cited by 19
Richardson, T. G., Mykkänen, J., Pahkala, K., Ala‐Korpela, M., Bell, J. A., Taylor, K., Viikari, J. S. A., Lehtimäki, T. J., Raitakari, O. T., & Smith, G. D. (2020) · medRxiv · doi:10.1101/2020.08.25.20181412 · Cited by 19
Self-citationJohannesen, C. D. L., Mortensen, M. B., Nordestgaard, B. G., & Langsted, A. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119139 · Cited by 27
Yang, G., & Schooling, C. M. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01714-2 · Cited by 18
Yun, Z., Nan, M., Li, X. Y., Liu, Z., Xu, J., Du, X., Dong, Q., & Hou, L. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1078963 · Cited by 22
Yang, G., & Schooling, C. M. (2023) · BMC Medicine · doi:10.1186/s12916-023-02903-w · Cited by 20
Huang, B. L., DePaolo, J. S., Judy, R., Shakt, G. E., Witschey, W. R. T., Levin, M. G., & Gershuni, V. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0293017 · Cited by 23
Guay, S., Paquette, M., Taschereau, A., Girard, L., Desgagné, V., Bouchard, L., Bernard, S., & Baass, A. W. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117489 · Cited by 19
Metadata
- Authors
- Richardson, T. G., Sanderson, E., Palmer, T. M., Ala-Korpela, M., Ference, B. A., Davey Smith, G., & Holmes, M. V.
- Affiliations
- University of Bristol (GB)
- University of Cambridge (GB)
- Corresponding author
- Richardson, Tom G.
- ORCID
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-03-23
- Volume
- 17
- Issue
- 3
- Pages
- e1003062
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC7089422
- OpenAlex
- W3012570809
- Cited by
- 843
- References
- 79
- Citations by year
- 2026: 68 · 2025: 132 · 2024: 206 · 2023: 190 · 2022: 124 · 2021: 91 · 2020: 30
- FWCI
- 67.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Lancaster EPrints (Lancaster University) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Bristol Research (University of Bristol) (submittedVersion, cc-by-nc-nd)
- Explore Bristol Research (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Medical Research Council (MC_UU_00011/1 and MC_UU-00011/2, MRC PHRU Oxford)
- UKRI (MR/S003886/1)
- National Health and Medical Research Council (APP1158958)
- Sigrid Juselius Foundation, Finland
- NIHR Cambridge Biomedical Research Centre
- British Heart Foundation (FS/18/23/33512)
- NIHR Oxford Biomedical Research Centre (Obesity theme)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- coronary artery disease, lipoprotein lipids, apolipoproteins, LDL cholesterol, triglycerides, HDL cholesterol, apolipoprotein B, apolipoprotein A-I, genetic instruments, causal inference, single nucleotide polymorphisms, genetic risk factors, UK Biobank
- MeSH terms
- Adult, Aged, Coronary Disease, Female, Humans, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Phenotype, Risk Factors, Triglycerides, Biomarkers, Multivariate Analysis, Apolipoprotein A-I, Risk Assessment, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Apolipoprotein B-100, Genome-Wide Association Study, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.